Task: Answer the multiple-choice question.
Question: Which drug exhibits a 0.581% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) COCCCNC(=S)N1CCN(c2nc(-c3cccc(OC)c3)cs2)CC1
(b) CC(C)C(=O)NCCc1nc(-c2ccccc2)no1
(c) CCN(CC)c1cccc(OC2=NS(=O)(=O)c3ccccc32)c1
Answer: b. CC(C)C(=O)NCCc1nc(-c2ccccc2)no1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)C(=O)NCCc1nc(-c2ccccc2)no1
CC(C)C(=O)NCCc1nc(-c2ccccc2)no1
2-methyl-N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]propanamide